Epidemiology and risk factors for age-related macular degeneration

Retina Fifth Edition

Volumn , Issue , 2012, Pages 1134-1144

  Seddon, Johanna M ^a,b   Sobrin, Lucia ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906796450     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-0737-9.00063-1     Document Type: Chapter

References (185)

1. Friedman DS., O’Colmain BJ., Munoz B., et al. Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564-572.
2. Bressler NM., Bressler SB., Congdon NG., et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11 Arch Ophthalmol 121 2003 1621-1624.
3. Rein DB., Wittenborn JS., Zhang X., et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments Arch Ophthalmol 127 2009 533-540.
4. AREDS Research Study Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 Arch Ophthalmol 119 2001 1417-1436.
5. Seddon JM., Willett WC., Speizer FE., et al. A prospective study of cigarette smoking and age-related macular degeneration in women JAMA 276 1996 1141-1146.
6. Tomany SC., Wang JJ., Van Leeuwen R., et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents Ophthalmology 111 2004 1280-1287.
7. Cho E., Seddon JM., Rosner B., et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy Arch Ophthalmol 122 2004 883-892.
8. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group Arch Ophthalmol 111 1993 104-109.
9. Mares-Perlman JA., Brady WE., Klein R., et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study Arch Ophthalmol 113 1995 1518-1523.
10. Seddon JM., Ajani UA., Sperduto RD., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group JAMA 272 1994 1413-1420.
11. Seddon JM., Cote J., Rosner B Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake Arch Ophthalmol 121 2003 1728-1737.
12. Seddon JM., Rosner B., Sperduto RD., et al. Dietary fat and risk for advanced age-related macular degeneration Arch Ophthalmol 119 2001 1191-1199.
13. Seddon JM., Cote J., Davis N., et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio Arch Ophthalmol 121 2003 785-792.
14. Seddon J., et al. Dietary fat intake and age-related macular degeneration Invest Ophthalmol Vis Sci 35 1994 ARVO abstract 2003.
15. Klein RJ., Zeiss C., Chew EY., et al. Complement factor H polymorphism in age-related macular degeneration Science 308 2005 385-389.
16. Edwards AO., Ritter R 3rd., Abel KJ., et al. Complement factor H polymorphism and age-related macular degeneration Science 308 2005 421-424.
17. Haines JL., Hauser MA., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration Science 308 2005 419-421.
18. Hageman GS., Anderson DH., Johnson LV., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration Proc Natl Acad Sci U S A 102 2005 7227-7232.
19. Rivera A., Fisher SA., Fritsche LG., et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk Hum Mol Genet 14 2005 3227-3236.
20. Dewan A., Liu M., Hartman S., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration Science 314 2006 989-992.
21. Yang Z., Camp NJ., Sun H., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration Science 314 2006 992-993.
22. Gold B., Merriam JE., Zernant J., et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration Nat Genet 38 2006 458-462.
23. Maller J., George S., Purcell S., et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration Nat Genet 38 2006 1055-1059.
24. Yates JR., Sepp T., Matharu BK., et al. Complement C3 variant and the risk of age-related macular degeneration N Engl J Med 357 2007 553-561.
25. Maller JB., Fagerness JA., Reynolds RC., et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration Nat Genet 39 2007 1200-1201.
26. Fagerness JA., Maller JB., Neale BM., et al. Variation near complement factor I is associated with risk of advanced AMD Eur J Hum Genet 17 2009 100-104.
27. Neale BM., Fagerness J., Reynolds R., et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) Proc Natl Acad Sci U S A 107 2010 7395-7400.
28. Chen W., Stambolian D., Edwards AO., et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration Proc Natl Acad Sci U S A 107 2010 7401-7406.
29. Yu Y., Bhangale T., Fagerness J., et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration Hum Mol Genet 20 18 2011 3699-3709.
30. Seddon JM., Francis PJ., George S., et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration JAMA 297 2007 1793-1800.
31. Seddon JM., Reynolds R., Maller J., et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables Invest Ophthalmol Vis Sci 50 2009 2044-2053.
32. Seddon JM., Reynolds R., Yu Y., et al. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic and ocular factors Ophthalmology 118 11 2011 2203-2211.
33. Bird AC., Bressler NM., Bressler SB., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group Surv Ophthalmol 39 1995 367-374.
34. Seddon JM., Sharma S., Adelman RA Evaluation of the clinical age-related maculopathy staging system Ophthalmology 113 2006 260-266.
35. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1 Control Clin Trials 20 1999 573-600.
36. Seddon JM., Santangelo SL., Book K., et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions Am J Hum Genet 73 2003 780-790.
37. Sobrin L., Reynolds R., Yu Y., et al. ARMS2/HTRA1 Locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration Am J Ophthalmol 151 2010 345-352.
38. Sobrin L., Maller JB., Neale BM., et al. Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach Eur J Hum Genet 18 2010 496-501.
39. Raychaudhuri S., Ripke S., Li M., et al. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent Nat Genet 42 2010 553-555.
40. Bressler NM., Bressler SB., West SK., et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen Arch Ophthalmol 107 1989 847-852.
41. Klein R., Davis MD., Magli YL., et al. The Wisconsin age-related maculopathy grading system Ophthalmology 98 1991 1128-1134.
42. Klein R., Rowland ML., Harris MI., Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey Ophthalmology 102 1995 371-381.
43. Klein R., Chou CF., Klein BE., et al. Prevalence of age-related macular degeneration in the US population Arch Ophthalmol 129 2011 75-80.
44. Leibowitz HM., Krueger DE., Maunder LR., et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975 Surv Ophthalmol 24 1980 335-610.
45. Klein R., Klein BE., Linton KL Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 1992 933-943.
46. Friedman DS., Katz J., Bressler NM., et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey Ophthalmology 106 1999 1049-1055.
47. West SK., Munoz B., Rubin GS., et al. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation Invest Ophthalmol Vis Sci 38 1997 72-82.
48. Vingerling JR., Dielemans I., Hofman A., et al. The prevalence of age-related maculopathy in the Rotterdam Study Ophthalmology 102 1995 205-210.
49. Mitchell P., Smith W., Attebo K., et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study Ophthalmology 102 1995 1450-1460.
50. Schachat AP., Hyman L., Leske MC., et al. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group Arch Ophthalmol 113 1995 728-735.
51. Pagliarini S., Moramarco A., Wormald RP., et al. Age-related macular disease in rural southern Italy Arch Ophthalmol 115 1997 616-622.
52. Podgor MJ., Leske MC., Ederer F Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy Am J Epidemiol 118 1983 206-212.
53. Klein R., Klein BE., Jensen SC., et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 1997 7-21.
54. Mukesh BN., Dimitrov PN., Leikin S., et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project Ophthalmology 111 2004 1176-1182.
55. Leske MC., Wu SY., Hyman L., et al. Four-year incidence of macular changes in the Barbados Eye Studies Ophthalmology 111 2004 706-711.
56. Klein R., Knudtson MD., Lee KE., et al. Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study Ophthalmology 115 2008 1460-1467.
57. Clemons TE., Chew EY., Bressler SB., et al. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report no. 10 Arch Ophthalmol 121 2003 211-217.
58. Mitchell J., Wolffsohn J., Woodcock A., et al. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness Am J Ophthalmol 146 2008 447-454.
59. Alexander MF., Maguire MG., Lietman TM., et al. Assessment of visual function in patients with age-related macular degeneration and low visual acuity Arch Ophthalmol 106 1988 1543-1547.
60. Mangione CM., Gutierrez PR., Lowe G., et al. Influence of age-related maculopathy on visual functioning and health-related quality of life Am J Ophthalmol 128 1999 45-53.
61. Brody BL., Gamst AC., Williams RA., et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration Ophthalmology 108 2001 1893-1900 discussion 900-1.
62. Casten RJ., Rovner BW., Tasman W Age-related macular degeneration and depression: a review of recent research Curr Opin Ophthalmol 15 2004 181-183.
63. Rovner BW., Casten RJ., Tasman WS Effect of depression on vision function in age-related macular degeneration Arch Ophthalmol 120 2002 1041-1044.
64. Javitt JC., Zhou Z., Maguire MG., et al. Incidence of exudative age-related macular degeneration among elderly Americans Ophthalmology 110 2003 1534-1539.
65. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report no. 3 Ophthalmology 107 2000 2224-2232.
66. Sommer A., Tielsch JM., Katz J., et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore N Engl J Med 325 1991 1412-1417.
67. Cruickshanks KJ., Hamman RF., Klein R., et al. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy Arch Ophthalmol 115 1997 242-250.
68. Varma R., Fraser-Bell S., Tan S., et al. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study Ophthalmology 111 2004 1288-1297.
69. Kawasaki R., Yasuda M., Song SJ., et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis Ophthalmology 117 2010 921-927.
70. Adler NE., Boyce WT., Chesney MA., et al. Socioeconomic inequalities in health. No easy solution JAMA 269 1993 3140-3145.
71. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group Arch Ophthalmol 110 1992 1701-1708.
72. Klein R., Klein BE., Jensen SC., et al. The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision. The Beaver Dam Eye Study Ophthalmology 101 1994 1969-1979.
73. Hyman LG., Lilienfeld AM., Ferris FL 3rd., et al. Senile macular degeneration: a case-control study Am J Epidemiol 118 1983 213-227.
74. Chaine G., Hullo A., Sahel J., et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group Br J Ophthalmol 82 1998 996-1002.
75. Maltzman BA., Mulvihill MN., Greenbaum A Senile macular degeneration and risk factors: a case-control study Ann Ophthalmol 11 1979 1197-1201.
76. Wang JJ., Mitchell P., Smith W Refractive error and age-related maculopathy: the Blue Mountains Eye Study Invest Ophthalmol Vis Sci 39 1998 2167-2171.
77. Ikram MK., van Leeuwen R., Vingerling JR., et al. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study Invest Ophthalmol Vis Sci 44 2003 3778-3782.
78. Friedman E., Ivry M., Ebert E., et al. Increased scleral rigidity and age-related macular degeneration Ophthalmology 96 1989 104-108.
79. Frank RN., Puklin JE., Stock C., et al. Race, iris color, and age-related macular degeneration Trans Am Ophthalmol Soc 98 2000 109-115 discussion 15-7.
80. Holz FG., Piguet B., Minassian DC., et al. Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration Am J Ophthalmol 117 1994 19-23.
81. Mitchell P., Smith W., Wang JJ Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study Ophthalmology 105 1998 1359-1363.
82. Sandberg MA., Gaudio AR., Miller S., et al. Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 35 1994 2734-2740.
83. Weiter JJ., Delori FC., Wing GL., et al. Relationship of senile macular degeneration to ocular pigmentation Am J Ophthalmol 99 1985 185-187.
84. Gibson JM., Shaw DE., Rosenthal AR Senile cataract and senile macular degeneration: an investigation into possible risk factors Trans Ophthalmol Soc U K 105 Pt 4 1986 463-468.
85. Klein R., Klein BE., Jensen SC., et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy Arch Ophthalmol 116 1998 506-513.
86. Tomany SC., Klein R., Klein BE The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 110 2003 1526-1533.
87. Wang JJ., Jakobsen K., Smith W., et al. Five-year incidence of age-related maculopathy in relation to iris, skin or hair colour, and skin sun sensitivity: the Blue Mountains Eye Study Clin Experiment Ophthalmol 31 2003 317-321.
88. West SK., Rosenthal FS., Bressler NM., et al. Exposure to sunlight and other risk factors for age-related macular degeneration Arch Ophthalmol 107 1989 875-879.
89. Sperduto RD., Hiller R., Seigel D Lens opacities and senile maculopathy Arch Ophthalmol 99 1981 1004-1008.
90. Liu IY., White L., LaCroix AZ The association of age-related macular degeneration and lens opacities in the aged Am J Public Health 79 1989 765-769.
91. Klein R., Klein BE., Wang Q., et al. Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112 1994 191-196.
92. Lundstrom M., Brege KG., Floren I., et al. Cataract surgery and quality of life in patients with age related macular degeneration Br J Ophthalmol 86 2002 1330-1335.
93. Freeman EE., Munoz B., West SK., et al. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies Am J Ophthalmol 135 2003 849-856.
94. Chew EY., Sperduto RD., Milton RC., et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report no. 25 Ophthalmology 116 2009 297-303.
95. Dong LM., Stark WJ., Jefferys JL., et al. Progression of age-related macular degeneration after cataract surgery Arch Ophthalmol 127 2009 1412-1419.
96. Christen WG., Glynn RJ., Manson JE., et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men JAMA 276 1996 1147-1151.
97. Klein R., Klein BE., Franke T The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 100 1993 406-414.
98. Klein R., Klein BE., Tomany SC., et al. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study Am J Epidemiol 156 2002 589-598.
99. Delcourt C., Diaz JL., Ponton-Sanchez A., et al. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l’Age Arch Ophthalmol 116 1998 1031-1035.
100. Suner IJ., Espinosa-Heidmann DG., Marin-Castano ME., et al. Nicotine increases size and severity of experimental choroidal neovascularization Invest Ophthalmol Vis Sci 45 2004 311-317.
101. Seddon JM., George S., Rosner B., et al. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration Hum Hered 61 2006 157-165.
102. Francis PJ., George S., Schultz DW., et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration Hum Hered 63 2007 212-218.
103. Bone RA., Landrum JT., Guerra LH., et al. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans J Nutr 133 2003 992-998.
104. Krinsky NI., Landrum JT., Bone RA Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye Annu Rev Nutr 23 2003 171-201.
105. Bernstein PS., Delori FC., Richer S., et al. The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders Vision Res 50 2010 716-728.
106. Evereklioglu C., Er H., Doganay S., et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration Doc Ophthalmol 106 2003 129-136.
107. Anderson RE., Kretzer FL., Rapp LM Free radicals and ocular disease Adv Exp Med Biol 366 1994 73-86.
108. Anderson RE., Rapp LM., Wiegand RD Lipid peroxidation and retinal degeneration Curr Eye Res 3 1984 223-227.
109. Young RW Pathophysiology of age-related macular degeneration Surv Ophthalmol 31 1987 291-306.
110. Hopley C., Salkeld G., Wang JJ., et al. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants Br J Ophthalmol 88 2004 450-454.
111. Richer S., Stiles W., Statkute L., et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial) Optometry 75 2004 216-230.
112. Gale CR., Hall NF., Phillips DI., et al. Lutein and zeaxanthin status and risk of age-related macular degeneration Invest Ophthalmol Vis Sci 44 2003 2461-2465.
113. Goldberg J., Flowerdew G., Smith E., et al. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey Am J Epidemiol 128 1988 700-710.
114. SanGiovanni JP., Chew EY., Clemons TE., et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22 Arch Ophthalmol 125 2007 1225-1232.
115. Vinding T., Appleyard M., Nyboe J., et al. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals Acta Ophthalmol (Copenh) 70 1992 66-72.
116. Obisesan TO., Hirsch R., Kosoko O., et al. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1 J Am Geriatr Soc 46 1998 1-7.
117. Cho E., Hankinson SE., Willett WC., et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration Arch Ophthalmol 118 2000 681-688.
118. Smith W., Mitchell P Alcohol intake and age-related maculopathy Am J Ophthalmol 122 1996 743-745.
119. Klein BE., Klein R., Lee KE., et al. Measures of obesity and age-related eye diseases Ophthalmic Epidemiol 8 2001 251-262.
120. Delcourt C., Michel F., Colvez A., et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study Ophthalmic Epidemiol 8 2001 237-249.
121. Schaumberg DA., Christen WG., Hankinson SE., et al. Body mass index and the incidence of visually significant age-related maculopathy in men Arch Ophthalmol 119 2001 1259-1265.
122. Smith W., Mitchell P., Leeder SR., et al. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study Arch Ophthalmol 116 1998 583-587.
123. Cruickshanks KJ., Klein R., Klein BE Sunlight and age-related macular degeneration. The Beaver Dam Eye Study Arch Ophthalmol 111 1993 514-518.
124. Cruickshanks KJ., Klein R., Klein BE., et al. Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study Arch Ophthalmol 119 2001 246-250.
125. Tomany SC., Cruickshanks KJ., Klein R., et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study Arch Ophthalmol 122 2004 750-757.
126. Delcourt C., Carriere I., Ponton-Sanchez A., et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l’Age (POLA) study Arch Ophthalmol 119 2001 1463-1468.
127. Darzins P., Mitchell P., Heller RF Sun exposure and age-related macular degeneration. An Australian case-control study Ophthalmology 104 1997 770-776.
128. Hyman L., Schachat AP., He Q., et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group Arch Ophthalmol 118 2000 351-358.
129. Wilson HL., Schwartz DM., Bhatt HR., et al. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration Am J Ophthalmol 137 2004 615-624.
130. Hall NF., Gale CR., Syddall H., et al. Risk of macular degeneration in users of statins: cross-sectional study BMJ 323 2001 375-376.
131. van Leeuwen R., Vingerling JR., Hofman A., et al. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement BMJ 326 2003 255-256.
132. Hall NF., Martyn CN Could statins prevent age-related macular degeneration? Expert Opin Pharmacother 3 2002 803-807.
133. Seddon JM., Gensler G., Milton RC., et al. Association between C-reactive protein and age-related macular degeneration JAMA 291 2004 704-710.
134. Klein R., Klein BE., Tomany SC., et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 110 2003 1273-1280.
135. Snow KK., Seddon JM Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 6 1999 125-143.
136. van Leeuwen R., Ikram MK., Vingerling JR., et al. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study Invest Ophthalmol Vis Sci 44 2003 3771-3777.
137. Vingerling JR., Dielemans I., Bots ML., et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study Am J Epidemiol 142 1995 404-409.
138. Hirvela H., Luukinen H., Laara E., et al. Risk factors of age-related maculopathy in a population 70 years of age or older Ophthalmology 103 1996 871-877.
139. Vinding T Age-related macular degeneration. An epidemiological study of 1000 elderly individuals. With reference to prevalence, funduscopic findings, visual impairment and risk factors Acta Ophthalmol Scand Suppl 1995 1-32.
140. Sperduto RD., Hiller R Systemic hypertension and age-related maculopathy in the Framingham Study Arch Ophthalmol 104 1986 216-219.
141. Delaney WV Jr., Oates RP Senile macular degeneration: a preliminary study Ann Ophthalmol 14 1982 21-24.
142. Kahn HA., Leibowitz HM., Ganley JP., et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study Am J Epidemiol 106 1977 33-41.
143. Vidaurri JS., Pe’er J., Halfon ST., et al. Association between drusen and some of the risk factors for coronary artery disease Ophthalmologica 188 1984 243-247.
144. Klein R., Klein BE., Jensen SC The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 1997 1804-1812.
145. Klein R., Klein BE., Tomany SC., et al. The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam eye study Am J Ophthalmol 137 2004 435-444.
146. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group Arch Ophthalmol 115 1997 741-747.
147. Reynolds R., Rosner B., Seddon JM Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration Ophthalmology 117 2010 1989-1995.
148. Klein R., Klein BE., Marino EK., et al. Early age-related maculopathy in the cardiovascular health study Ophthalmology 110 2003 25-33.
149. van Leeuwen R., Klaver CC., Vingerling JR., et al. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 137 2004 750-752.
150. Christen WG., Schaumberg DA., Glynn RJ., et al. Dietary Ω-3 fatty acid and fish intake and incident age-related macular degeneration in women Arch Ophthalmol 129 2011 921-929.
151. Mares-Perlman JA., Brady WE., Klein R., et al. Dietary fat and age-related maculopathy Arch Ophthalmol 113 1995 743-748.
152. Heuberger RA., Mares-Perlman JA., Klein R., et al. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey Arch Ophthalmol 119 2001 1833-1838.
153. SanGiovanni JP., Chew EY., Agron E., et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 Arch Ophthalmol 126 2008 1274-1279.
154. Friedman E Dietary fat and age-related maculopathy Arch Ophthalmol 114 1996 235-236.
155. Klein R., Klein BE., Moss SE Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 1992 1527-1534.
156. Snow KK., Cote J., Yang W., et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women Am J Ophthalmol 134 2002 842-848.
157. Snow KK., Seddon JM Age-related eye diseases: impact of hormone replacement therapy, and reproductive and other risk factors Int J Fertil Womens Med 45 2000 301-313.
158. Klein BE., Klein R., Jensen SC., et al. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study Trans Am Ophthalmol Soc 92 1994 289-295 discussion 95-7.
159. Smith W., Mitchell P., Wang JJ Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study Aust N Z J Ophthalmol 25 Suppl 1 1997 S13-S15.
160. Defay R., Pinchinat S., Lumbroso S., et al. Sex steroids and age-related macular degeneration in older French women: the POLA study Ann Epidemiol 14 2004 202-208.
161. Abramov Y., Borik S., Yahalom C., et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women Menopause 11 2004 62-68.
162. Klein R., Deng Y., Klein BE., et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s Health Initiative Sight Exam ancillary study Am J Ophthalmol 143 2007 473-483.
163. Anderson DH., Mullins RF., Hageman GS., et al. A role for local inflammation in the formation of drusen in the aging eye Am J Ophthalmol 134 2002 411-431.
164. Johnson LV., Leitner WP., Staples MK., et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration Exp Eye Res 73 2001 887-896.
165. Mullins RF., Russell SR., Anderson DH., et al. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease FASEB J 14 2000 835-846.
166. Seddon JM., Gensler G., Rosner B C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration Ophthalmology 117 2010 1560-1566.
167. Becerra EM., Morescalchi F., Gandolfo F., et al. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration Curr Drug Targets 12 2011 149-172.
168. Soames CJ., Sim RB Interactions between human complement components factor H, factor I and C3b Biochem J 326 Pt 2 1997 553-561.
169. Gehrs KM., Jackson JR., Brown EN., et al. Complement, age-related macular degeneration and a vision of the future Arch Ophthalmol 128 2010 349-358.
170. Seddon JM., Sobrin L Epidemiology of age-related macular degeneration In: Albert D., Miller J., Azar D., et al. Albert & Jakobiec’s Principles and practice of ophthalmology 2007 W.B. Saunders Philadelphia 413-422.
171. Seddon JM., Ajani UA., Mitchell BD Familial aggregation of age-related maculopathy Am J Ophthalmol 123 1997 199-206.
172. Klaver CC., Wolfs RC., Assink JJ., et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study Arch Ophthalmol 116 1998 1646-1651.
173. Hughes AE., Orr N., Esfandiary H., et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration Nat Genet 38 2006 1173-1177.
174. Jakobsdottir J., Conley YP., Weeks DE., et al. Susceptibility genes for age-related maculopathy on chromosome 10q26 Am J Hum Genet 77 2005 389-407.
175. Sobrin L., Reynolds R., Yu Y., et al. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration Am J Ophthalmol 151 2 2011 345-352.
176. Weber BH., Vogt G., Pruett RC., et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby’s fundus dystrophy Nat Genet 8 1994 352-356.
177. Brantley MA Jr., Fang AM., King JM., et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab Ophthalmology 114 2007 2168-2173.
178. Nischler C., Oberkofler H., Ortner C., et al. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration Acta Ophthalmol 89 2011 e344-e349.
179. Lee AY., Raya AK., Kymes SM., et al. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab Br J Ophthalmol 93 2009 610-613.
180. Klein ML., Francis PJ., Rosner B., et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration Ophthalmology 115 2008 1019-1025.
181. Brantley MA Jr., Edelstein SL., King JM., et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy Eye (Lond) 23 2009 626-631.
182. Chowers I., Cohen Y., Goldenberg-Cohen N., et al. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel Mol Vis 14 2008 1829-1834.
183. Feng X., Xiao J., Longville B., et al. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration Ophthalmology 116 2009 1908-1912 e1.
184. Tsuchihashi T., Mori K., Horie-Inoue K., et al. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration Ophthalmology 118 2011 93-100.
185. Raychaudhuri S., Iartchouk O., Chin K., et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration Nat Genet 43 2011 1232-1236.